CASP9 and osteosarcoma: These findings indicate that the observed chemoresistance of IMPDH2-overexpressing osteosarcoma cells may be due at least in part to increased expression of anti-apoptotic proteins, reduced activation of caspase-9, and, as a consequence, decreased cleavage of PARP.